Global Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

According to our (Global Info Research) latest study, the global Albumin market size was valued at US$ 5883 million in 2023 and is forecast to a readjusted size of USD 9447 million by 2030 with a CAGR of 6.9% during review period.

Global albumin control main manufactuers include CSL, Grifols, Takeda, Octapharma, etc., totally accounting for about 58% of the market. Asia Pacific is the largest production market, with a share over 45%.

As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 77%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 64%.

This report is a detailed and comprehensive analysis for global Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Albumin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030

Global Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030

Global Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030

Global Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Albumin

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Biotest, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Albumin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin

Market segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others

Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Thermo Fisher
Merck
Cytiva
Proliant Biologicals
Sartorius

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Albumin product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Albumin, with price, sales quantity, revenue, and global market share of Albumin from 2019 to 2024.

Chapter 3, the Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin.

Chapter 14 and 15, to describe Albumin sales channel, distributors, customers, research findings and conclusion.